Article Details

Xilio Therapeutics Raises $95 Million in Series C Financing to Advance Potent Tumor-Selective ...

Retrieved on: 2021-02-24 10:52:30

Tags for this article:

Click the tags to see associated articles and topics

Xilio Therapeutics Raises $95 Million in Series C Financing to Advance Potent Tumor-Selective .... View article details on hiswai:

Excerpt

Xilio's existing investors, including Atlas Venture, SV Health Investors, Takeda Ventures, RiverVest Venture Partners, and MRL Ventures Fund, also ...

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo